ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2192

Association between Mitochondrial DNA (mtDNA) Haplogroups and Bone Marrow Lesions at 24 Months in Osteoarthritis Subjects: Subjets from the Osteoarthritis Initiative

Ignacio Rego-Pérez1, Jean-Pierre Pelletier2, François Abram3, Natividad Oreiro4, Carlos Fernandez-Lopez1, Ana Cecilia Raga1, Francisco J Blanco1 and Johanne Martel-Pelletier2, 1Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña. España, A Coruña, Spain, 2Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 3Medical Imaging Research & Development, ArthroLab Inc., Montreal, QC, Canada, 4Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña. España, A Coruna, Spain

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: bone marrow lesions, Knee, mitochondria and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Osteoarthritis – Clinical Aspects Poster II: Observational and Epidemiological Studies

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Bone marrow lesions (BMLs) have been consistently associated with the development of osteoarthritis (OA); however the extent to which they are genetically driven by mitochondrial genetic background is unknown. Since specific mtDNA haplogroups have been associated with decreased risk of incident knee OA, the aim of this work was to examine the associations between mtDNA haplogroups and MRI-detected BMLs

Methods: Knees that did not develop either incident OA or radiographic progression during 48 months follow-up were identified from 1030 Osteoarthritis Initiative (OAI) subjects. The most common Caucasian mtDNA haplogroups (H, Uk, J, T and Others) were assigned to all participants using the single base extension (SBE) assay. BML measurements from MR images acquired using IW-TSE sequence with sagittal slices in different knee regions were obtained annually between baseline and 24 months using an automated system, and were expressed as % of the bone region. Logistic regression with generalized estimating equations and multinomial logistic regression models were used to evaluate the association between mtDNA haplogroups and i) large BMLs, present at any point between baseline and 24 months and defined as ≥33% of the subregional bone volume, as well as ii) the progression of BMLs at 24 months according to an increase of ±1% volume between baseline and final visit. Both models were adjusted by confounder variables of gender, age and BMI. Participants with haplogroup H served as the reference group

Results: Participants included in this study had a mean age of 62,43 (sd 9,2), with a percentage of females of 54,1%. Haplogroups for the 1030 participants included H (n=419, 40,7%), J (n=88, 8,5%), T (109, 10,6%), Uk (n=236, 22,9%) and the less common haplogroups “others” (n=178, 17,3%).

Knees of participants with haplogroup J had significantly lower risk of large BMLs in lateral femur (OR=0,545;95%CI:0,299–0,996;p=0,048); in contrast, participants with haplogroup T had significantly increased risk of large BMLs in global tibia (OR=1,500;95%CI:1,020–2,206;p=0,039) and lateral plateau (OR=1,525;95%CI:1,003–2,320;p=0,048). No evidence of a protective or risk effect of any other haplogroup in the odds of large BMLs was detected in the rest of the knee compartments.

In terms of BMLs progression, participants with haplogroup J showed a lower risk of BML progression over time and an increased rate of no change in global femur compartment (OR=0,549;95%CI:0,309–0,977;p=0,041); participants with haplogroup T showed an increased rate of BML regression over time in global knee (OR=2,534;95%CI:1,236–5,195;p=0,011) as well as in medial plateau (OR=1,987;95%CI: 1,006–3,925;p=0,048). No other haplogroup was associated with the risk of BML progression for either knee region

Conclusion: mtDNA haplogroup J appeared to be OA protective, as it is associated with lower risk of large BMLs in lateral femur as well as a lower rate of BML progression over time in global femur. Interestingly, haplogroup T, despite its association with an increased risk of large BMLs, was significantly associated with BML regression rates in the whole knee. Both haplogroups J and T slow down the progression of BMLs


Disclosure: I. Rego-Pérez, None; J. P. Pelletier, Bioiberica, 5,ArthroLab, 9; F. Abram, ArthroLab, 3; N. Oreiro, None; C. Fernandez-Lopez, None; A. C. Raga, None; F. J. Blanco, None; J. Martel-Pelletier, Bioiberica, 5,ArthroLab, 9.

To cite this abstract in AMA style:

Rego-Pérez I, Pelletier JP, Abram F, Oreiro N, Fernandez-Lopez C, Raga AC, Blanco FJ, Martel-Pelletier J. Association between Mitochondrial DNA (mtDNA) Haplogroups and Bone Marrow Lesions at 24 Months in Osteoarthritis Subjects: Subjets from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/association-between-mitochondrial-dna-mtdna-haplogroups-and-bone-marrow-lesions-at-24-months-in-osteoarthritis-subjects-subjets-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-mitochondrial-dna-mtdna-haplogroups-and-bone-marrow-lesions-at-24-months-in-osteoarthritis-subjects-subjets-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology